## Objective There are few data concerning a clear relationship between the clinical effect of paroxetine and plasma drug concentrations, although therapeutic ranges have been established for some tricyclic antidepressants. ## Methods In this study, 120 patients with major depressive disorders we
Differences in clinical effect and tolerance between fluvoxamine and paroxetine: A switching study in patients with depression
β Scribed by Yutaro Suzuki; Nobuto Tsuneyama; Naoki Fukui; Takuro Sugai; Junzo Watanabe; Shin Ono; Toshiyuki Someya
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 67 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0885-6222
- DOI
- 10.1002/hup.1147
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Objective
We examined whether discontinuation and the responses to fluvoxamine (FLV) administration could predict the subsequent discontinuation and the responses to paroxetine (PRX) in patients with depression.
Methods
The subjects comprised 106 outpatients who were diagnosed with depression, and clinical evaluation was conducted every 2βweeks. Patients who discontinued FLV because of side effects or did not achieve remission with 200βmg/day of FLV, the drug was switched to PRX. The maximum dose of PRX was 40βmg/day.
Results
Among 10 patients who discontinued FLV, PRX was also discontinued in one patient. Of 33 patients without remission on FLV, PRX was discontinued because of side effects in two patients. There was no statistical difference in the discontinuation rates between the two groups. Four of 10 patients who discontinued FLV achieved remission, while nine of 33 patients without remission with FLV achieved remission with PRX. The remission rate was not significantly different between the two groups.
Conclusion
Discontinuation and the responses related to FLV could not serve as a predictor for the subsequent discontinuation and the responses related to PRX. Copyright Β© 2010 John Wiley & Sons, Ltd.
π SIMILAR VOLUMES
## Abstract Selective serotonin reuptake inhibitors (SSRIs) are widely used to treat both anxiety disorders and depressive disorders. However, nonadherence to SSRIs is a major issue in recurrence. In the present study, we investigated paroxetine adherence in depressed patients by monitoring the pla
## Abstract ## Objective Studies indicate that serotoninergic and noradrenergic pathophysiological mechanisms may underlie both alcohol abuse/dependence and depressive disorder. The purpose of this study was to evaluate and compare the effectiveness and tolerability of two serotonergic and noradre
## Abstract ## BACKGROUND Few studies have addressed the issue of whether delays in the interval between medical consultation and the diagnosis and treatment of breast carcinoma are greater for African American women than for white women. The authors examined differences with respect to these dela
## Abstract Hypophosphatemic rickets (HR) are diseases characterized by deficient mineralization of bone due to abnormal renal wasting of phosphate. Deformation of bony structures of cartilaginous origin has been described as a major characteristic in patients with HR, but little is known about the